Logo image of CBNA

CHAIN BRIDGE BANCORP INC-A (CBNA) Stock Fundamental Analysis

NYSE:CBNA - New York Stock Exchange, Inc. - US15746L1008 - Common Stock - Currency: USD

26.59  -0.33 (-1.23%)

Fundamental Rating

4

Taking everything into account, CBNA scores 4 out of 10 in our fundamental rating. CBNA was compared to 394 industry peers in the Banks industry. While CBNA seems to be doing ok healthwise, there are quite some concerns on its profitability. CBNA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

CBNA had positive earnings in the past year.
CBNA Yearly Net Income VS EBIT VS OCF VS FCFCBNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 5M 10M 15M 20M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.54%, CBNA belongs to the top of the industry, outperforming 90.61% of the companies in the same industry.
CBNA has a Return On Equity of 17.53%. This is amongst the best in the industry. CBNA outperforms 96.19% of its industry peers.
Industry RankSector Rank
ROA 1.54%
ROE 17.53%
ROIC N/A
ROA(3y)1.01%
ROA(5y)N/A
ROE(3y)12.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CBNA Yearly ROA, ROE, ROICCBNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 5 10

1.3 Margins

CBNA has a better Profit Margin (39.35%) than 94.92% of its industry peers.
The Operating Margin and Gross Margin are not available for CBNA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 39.35%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBNA Yearly Profit, Operating, Gross MarginsCBNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

CBNA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CBNA has more shares outstanding
There is no outstanding debt for CBNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CBNA Yearly Shares OutstandingCBNA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M
CBNA Yearly Total Debt VS Total AssetsCBNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B

2.2 Solvency

CBNA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC10.63%
CBNA Yearly LT Debt VS Equity VS FCFCBNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 50M 100M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CBNA Yearly Current Assets VS Current LiabilitesCBNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M

More info and screens

4

3. Growth

3.1 Past

CBNA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 132.05%, which is quite impressive.
CBNA shows a strong growth in Revenue. In the last year, the Revenue has grown by 70.68%.
EPS 1Y (TTM)132.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)70.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -6.96% on average over the next years.
Based on estimates for the next years, CBNA will show a quite strong growth in Revenue. The Revenue will grow by 8.21% on average per year.
EPS Next Y-38.57%
EPS Next 2Y-6.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.35%
Revenue Next 2Y8.21%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

CBNA Yearly Revenue VS EstimatesCBNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
CBNA Yearly EPS VS EstimatesCBNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 1 2 3 4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 6.47, the valuation of CBNA can be described as very cheap.
CBNA's Price/Earnings ratio is rather cheap when compared to the industry. CBNA is cheaper than 95.69% of the companies in the same industry.
When comparing the Price/Earnings ratio of CBNA to the average of the S&P500 Index (27.51), we can say CBNA is valued rather cheaply.
The Price/Forward Earnings ratio is 7.10, which indicates a rather cheap valuation of CBNA.
90.61% of the companies in the same industry are more expensive than CBNA, based on the Price/Forward Earnings ratio.
CBNA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.58.
Industry RankSector Rank
PE 6.47
Fwd PE 7.1
CBNA Price Earnings VS Forward Price EarningsCBNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBNA Per share dataCBNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

A cheap valuation may be justified as CBNA's earnings are expected to decrease with -6.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.96%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CBNA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHAIN BRIDGE BANCORP INC-A

NYSE:CBNA (7/14/2025, 8:04:00 PM)

26.59

-0.33 (-1.23%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-28 2025-04-28/amc
Earnings (Next)N/A N/A
Inst Owners45.66%
Inst Owner Change0%
Ins Owners25.13%
Ins Owner Change4.76%
Market Cap174.43M
Analysts80
Price Target30.26 (13.8%)
Short Float %4.24%
Short Ratio3.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.27%
Min EPS beat(2)5.17%
Max EPS beat(2)53.38%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)20.13%
Min Revenue beat(2)15.06%
Max Revenue beat(2)25.2%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.6%
EPS NY rev (1m)0%
EPS NY rev (3m)6.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.19%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.77%
Valuation
Industry RankSector Rank
PE 6.47
Fwd PE 7.1
P/S 2.58
P/FCF N/A
P/OCF N/A
P/B 1.15
P/tB 1.15
EV/EBITDA N/A
EPS(TTM)4.11
EY15.46%
EPS(NY)3.75
Fwd EY14.09%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.29
BVpS23.1
TBVpS23.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.54%
ROE 17.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 39.35%
GM N/A
FCFM N/A
ROA(3y)1.01%
ROA(5y)N/A
ROE(3y)12.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACC10.63%
ROIC/WACCN/A
Cap/Depr(3y)39.16%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.53%
Cap/Sales(5y)N/A
Profit Quality(3y)151.13%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)132.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-38.57%
EPS Next 2Y-6.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)70.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-0.35%
Revenue Next 2Y8.21%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.13%
OCF growth 3YN/A
OCF growth 5YN/A